Clinical signs that predict severe illness in children under age 2 months: a multicentre study

BACKGROUND Neonatal illness, particularly in the first week of life, is a leading cause of death worldwide. Improving identification of young infants who require referral for severe illness is of major public-health importance. METHODS Infants under 2 months of age brought with illness to health facilities in Bangladesh, Bolivia, Ghana, India, Pakistan, and South Africa were recruited in two age-groups: 0-6 days and 7-59 days. A trained health worker recorded 31 symptoms and clinical signs. An expert paediatrician assessed each case independently for severe illness that required hospital admission. We examined the sensitivity, specificity, and odds ratio (OR) for each symptom and sign individually and combined into algorithms to assess their value for predicting severe illness, excluding jaundice. FINDINGS 3177 children aged 0-6 days and 5712 infants aged 7-59 days were enrolled. 12 symptoms or signs predicted severe illness in the first week of life: history of difficulty feeding (OR 10.0, 95% CI, 6.9-14.5), history of convulsions (15.4, 6.4-37.2), lethargy (3.5, 1.7-7.1), movement only when stimulated (6.9, 3.0-15.5), respiratory rate of 60 breaths per minute or more (2.7, 1.9-3.8), grunting (2.9, 1.1-7.5), severe chest indrawing (8.9, 4.0-20.1), temperature of 37.5 degrees C or more (3.4, 2.4-4.9) or below 35.5 degrees C (9.2, 4.6-18.6), prolonged capillary refill (10.5, 5.1-21.7), cyanosis (13.7, 1.6-116.5), and stiff limbs (15.1, 2.2-105.9). A decision rule requiring the presence of any one sign had high sensitivity (87%) and specificity (74%). After we reduced the algorithm to seven signs (history of difficulty feeding, history of convulsions, movement only when stimulated, respiratory rate of 60 breaths per minute or more, severe chest indrawing, temperature of 37.5 degrees C or more or below 35.5 degrees C), mainly on the basis of prevalence of each sign or symptom, sensitivity (85%) and specificity (75%) were much the same. These seven signs also did well in 7-59-day-old infants (sensitivity 74%, specificity 79%). INTERPRETATION A single simple algorithm could be recommended for identifying severe illness in infants aged 0-2 months who are brought to health facilities. Further research is needed on screening newborn children for illness in the community during routine home visits.

[1]  J. Carlin,et al.  Clinico-epidemiological profile and validation of symptoms and signs of severe illness in young infants (< 60 days) reporting to a district hospital. , 2007, Indian pediatrics.

[2]  S. Gatchalian,et al.  Bacterial and viral etiology of serious infections in very young Filipino infants. , 1999, The Pediatric infectious disease journal.

[3]  J. Tulloch Integrated approach to child health in developing countries , 1999, The Lancet.

[4]  H. Whittle,et al.  Etiology of serious infections in young Gambian infants. , 1999, The Pediatric infectious disease journal.

[5]  V. Paul,et al.  Simple Clinical Criteria to Identify Sepsis or Pneumonia in Neonates in the Community Needing Treatment or Referral , 2005, The Pediatric infectious disease journal.

[6]  M. Alpers,et al.  Bacterial and viral etiology of severe infection in children less than three months old in the highlands of Papua New Guinea. , 1999, The Pediatric infectious disease journal.

[7]  J. Carlin,et al.  Predictors of neonatal sepsis in developing countries , 2003, The Pediatric infectious disease journal.

[8]  S. Gove,et al.  Etiology of pneumonia, sepsis and meningitis in infants younger than three months of age in Ethiopia. , 1999, The Pediatric infectious disease journal.

[9]  S. Cousens,et al.  4 million neonatal deaths: When? Where? Why? , 2005, The Lancet.

[10]  S. Jaffar,et al.  Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia. , 1997, Bulletin of the World Health Organization.

[11]  Z. Bhutta,et al.  Hospital-acquired neonatal infections in developing countries , 2005, The Lancet.